Immuneering (IMRX) Depreciation and Depletion (2020 - 2024)
Immuneering (IMRX) recorded quarterly Depreciation and Depletion of $86116.0 in Q4 2024, down 3.18% quarter-over-quarter from $88949.0 in Q3 2024, and down 4.05% on a YoY basis from $89754.0 in Q1 2024.
Immuneering (IMRX) Depreciation and Depletion (2020 - 2024) Analysis & Trends
Immuneering's Depreciation and Depletion history runs 5 years deep, the most recent figure standing at $86116.0 for Q4 2024.
- In Q4 2024, Depreciation and Depletion fell 4.05% year-over-year to $86116.0; the TTM figure through Dec 2024 stood at $355807.0 (up 10.22% YoY), while the FY2024 annual figure was $355807.0, up 10.22% from the prior year.
- Depreciation and Depletion was $86116.0 for Q4 2024 at Immuneering, down from $88949.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $90533.0 in Q2 2024 to a low of $5656.0 in Q3 2020.
- Historically, Depreciation and Depletion has averaged $52121.7 across 5 years, with a median of $68075.0 in 2022.
- The sharpest annual moves came in 2022 and 2024: Depreciation and Depletion surged 468.33% in 2022, then slipped 4.05% in 2024.
- A 5-year view of Depreciation and Depletion shows it stood at $7449.0 in 2020, then jumped by 98.89% to $14815.0 in 2021, then soared by 418.81% to $76862.0 in 2022, then climbed by 16.77% to $89754.0 in 2023, then decreased by 4.05% to $86116.0 in 2024.
- The last three Depreciation and Depletion figures came in at $86116.0 (Q4 2024), $88949.0 (Q3 2024), and $90533.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Immuneering | 255.40 Mn | 255.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 86,116.00 |
| Dec 31, 2024 | 86,116.00 |
| Sep 30, 2024 | 88,949.00 |
| Sep 30, 2024 | 88,949.00 |
| Jun 30, 2024 | 90,533.00 |
| Jun 30, 2024 | 90,533.00 |
| Mar 31, 2024 | 90,209.00 |
| Mar 31, 2024 | 90,209.00 |
| Dec 31, 2023 | 89,754.00 |
| Dec 31, 2023 | 89,754.00 |
| Sep 30, 2023 | 78,294.00 |
| Sep 30, 2023 | 78,294.00 |
| Jun 30, 2023 | 78,241.00 |
| Jun 30, 2023 | 78,241.00 |
| Mar 31, 2023 | 76,527.00 |
| Mar 31, 2023 | 76,527.00 |
| Dec 31, 2022 | 76,862.00 |
| Dec 31, 2022 | 76,862.00 |
| Sep 30, 2022 | 68,075.00 |
| Sep 30, 2022 | 68,075.00 |